1. FRI0246 Magnetic Resonance Imaging-Assessment of Early Response to Certolizumab Pegol in Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase Iiib Study Applying Magnetic Resonance Imaging at Weeks 0, 1, 2, 4, 8 and 16. (10th June 2014) Authors: Østergaard, M.; Jacobsson, L.; Schaufelberger, C.; Sejer-Hansen, M.; Bijlsma, J.; Dudek, A.; Rell-Bakalarska, M.; Staelens, F.; Haake, R.; Sundman-Engberg, B.; Bliddal, H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗